ITGB4 Gene: Integrin Subunit Beta 4

Key mediator of hemidesmosome assembly, epithelial integrity, and signaling in development and cancer.

Gene Information Card

Symbol ITGB4
Full Name Integrin Subunit Beta 4
Gene Type protein coding
Chromosomal Location 17q25.1
NCBI Gene ID 3691 ncbi.nlm.nih.gov/gene/3691
Ensembl ID ENSG00000132470
UniProt ID P16144
OMIM ID 147557
HGNC ID 6158
Aliases CD104, GP150

Description

ITGB4 encodes the integrin beta-4 subunit, which pairs with integrin alpha-6 to form the α6β4 integrin, a major receptor for laminins. This integrin is a critical component of hemidesmosomes, anchoring epithelial cells to the basement membrane. Beyond adhesion, ITGB4 participates in signaling pathways that regulate cell survival, proliferation, and migration, with implications in development and cancer progression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Epidermolysis Bullosa (Junctional, with Pyloric Atresia) Loss-of-function mutations in ITGB4 disrupt hemidesmosome formation, leading to skin fragility and blistering. ClinVar; OMIM
Epidermolysis Bullosa (Non-Herlitz Junctional) Mutations affecting ITGB4 impair basement membrane adhesion, causing chronic skin blistering. ClinVar; OMIM
Cancer (various types, e.g., breast, pancreatic) Overexpression or altered signaling of ITGB4 promotes tumor invasion and metastasis via PI3K/Akt and other pathways. COSMIC; PubMed (via NCBI)

Expression Profile

Tissue Expression
Tissue nTPM level
Skin High High
Esophagus High High
Breast Medium Medium
Lung Medium Medium
Liver Low Low
Cell Line Expression
Cell Line nTPM Notes
A549 (Lung) Medium Epithelial-like expression
MCF7 (Breast) High Strong expression in adherent cells
HeLa (Cervical) Medium Detected in epithelial lines
HepG2 (Liver) Low Low expression in hepatocyte lines
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.3979C>T (p.Arg1327Ter) Nonsense Rare Loss of function; causes junctional epidermolysis bullosa with pyloric atresia
c.433G>A (p.Gly145Arg) Missense Rare Impairs integrin function; associated with skin fragility
c.3793G>A (p.Glu1265Lys) Missense Rare Alters ligand binding; linked to non-Herlitz junctional epidermolysis bullosa
Mutation functional classification

Loss of Function (LOF)

Most ITGB4 mutations are loss-of-function, leading to defective hemidesmosome assembly and skin blistering.

Gain of Function (GOF)

Gain-of-function mutations are rare; some cancer-associated variants may enhance signaling but are not well characterized.

Dominant Negative (DN)

Dominant-negative effects have been suggested in some missense mutations that disrupt heterodimer formation, but evidence is limited.

Gene Ontology (GO)

• integrin-mediated signaling pathway • cell adhesion
• hemidesmosome assembly • extracellular matrix organization
• cell-matrix adhesion • laminin binding
• protein heterodimerization activity

Pathways

PI3K-Akt signaling pathway
Focal adhesion
ECM-receptor interaction
Hemidesmosome assembly

Protein Summary

The integrin beta-4 subunit is a type I transmembrane protein with a large cytoplasmic domain (~1000 amino acids) that links to intermediate filaments via plectin and BP230. It forms the α6β4 integrin, which binds laminin-332 in the basement membrane. This interaction is essential for hemidesmosome stability. In addition to structural roles, ITGB4 activates signaling cascades (e.g., PI3K/Akt, MAPK) that promote cell survival and motility, contributing to cancer invasion when dysregulated.

Related Products

Product name Cat.No. Species Gene ID
ITGB4 Knockout HEK293 Cell Line EDJ-KQ819 Human 3691 Details Get a Quote
ITGB4 Knockout A-549 Cell Line EDJ-KQ19571 Human 3691 Details Get a Quote
ITGB4 Knockout HCT 116 Cell Line EDJ-KQ19572 Human 3691 Details Get a Quote
ITGB4 Knockout HeLa Cell Line EDJ-KQ19573 Human 3691 Details Get a Quote
ITGB4 Overexpression A-549 Stable Cell Line EDC90139 Human 3691 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: